Your browser doesn't support javascript.
loading
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients.
Ramos-Benitez, Marcos J; Strich, Jeffrey R; Alehashemi, Sara; Stein, Sydney; Rastegar, Andre; de Jesus, Adriana Almeida; Bhuyan, Farzana; Ramelli, Sabrina; Babyak, Ashley; Perez-Valencia, Luis; Vannella, Kevin M; Grubbs, Gabrielle; Khurana, Surender; Gross, Robin; Hadley, Kyra; Liang, Janie; Mazur, Steven; Postnikova, Elena; Warner, Seth; Holbrook, Michael R; Busch, Lindsay M; Warner, Blake; Applefeld, Willard; Warner, Sarah; Kadri, Sameer S; Davey, Richard T; Goldbach-Mansky, Raphaela; Chertow, Daniel S.
Afiliação
  • Ramos-Benitez MJ; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Strich JR; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Alehashemi S; Postdoctoral Research Associate Training Program, National Institute of General Medical Sciences, Bethesda, MD 20892.
  • Stein S; Ponce Health Science University and Ponce Research Institute, Department of Basic Sciences, School of Medicine, Ponce, Puerto Rico, USA.
  • Rastegar A; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.
  • de Jesus AA; The United States Public Health Service Commissioned Corps, Rockville, MD, USA.
  • Bhuyan F; Translational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy, and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Ramelli S; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Babyak A; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Perez-Valencia L; Translational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy, and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Vannella KM; Translational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy, and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Grubbs G; Translational Autoinflammatory Diseases Section (TADS), Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy, and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
  • Khurana S; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Gross R; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Hadley K; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Liang J; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Mazur S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Postnikova E; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Warner S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Holbrook MR; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD.
  • Busch LM; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD.
  • Warner B; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD.
  • Applefeld W; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD.
  • Warner S; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD.
  • Kadri SS; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD.
  • Davey RT; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD.
  • Goldbach-Mansky R; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Chertow DS; Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD.
medRxiv ; 2022 Nov 13.
Article em En | MEDLINE | ID: mdl-36415460

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article